Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302

1.

Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.

Syed V, Mukherjee K, Godoy-Tundidor S, Ho SM.

J Cell Biochem. 2007 Oct 1;102(2):442-52.

PMID:
17393432
2.

Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L/TRAIL.

Gómez-Benito M, Martinez-Lorenzo MJ, Anel A, Marzo I, Naval J.

Exp Cell Res. 2007 Jul 1;313(11):2378-88. Epub 2007 Mar 30.

PMID:
17462628
3.

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H.

Cell Death Differ. 2004 Jul;11 Suppl 1:S86-96.

4.

Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells.

Hao C, Beguinot F, Condorelli G, Trencia A, Van Meir EG, Yong VW, Parney IF, Roa WH, Petruk KC.

Cancer Res. 2001 Feb 1;61(3):1162-70.

5.
6.

Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level.

Morizot A, Mérino D, Lalaoui N, Jacquemin G, Granci V, Iessi E, Lanneau D, Bouyer F, Solary E, Chauffert B, Saas P, Garrido C, Micheau O.

Cell Death Differ. 2011 Apr;18(4):700-11. doi: 10.1038/cdd.2010.144. Epub 2010 Nov 12.

7.

Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.

Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A.

Gynecol Oncol. 2004 Jun;93(3):594-604.

PMID:
15196850
8.
9.

DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.

Bellail AC, Tse MC, Song JH, Phuphanich S, Olson JJ, Sun SY, Hao C.

J Cell Mol Med. 2010 Jun;14(6A):1303-17. doi: 10.1111/j.1582-4934.2009.00777.x. Epub 2009 May 11.

10.

α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway.

Yu W, Tiwary R, Li J, Park SK, Jia L, Xiong A, Simmons-Menchaca M, Sanders BG, Kline K.

Mol Carcinog. 2010 Nov;49(11):964-73. doi: 10.1002/mc.20681.

PMID:
20886583
11.

Molecular determinants of response to TRAIL in killing of normal and cancer cells.

Kim K, Fisher MJ, Xu SQ, el-Deiry WS.

Clin Cancer Res. 2000 Feb;6(2):335-46.

12.
15.

Downregulation of active caspase 8 as a mechanism of acquired TRAIL resistance in mismatch repair-proficient colon carcinoma cell lines.

Van Geelen CM, Pennarun B, Ek WB, Le PT, Spierings DC, De Vries EG, De Jong S.

Int J Oncol. 2010 Oct;37(4):1031-41.

PMID:
20811726
16.

Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis.

Saulle E, Petronelli A, Pasquini L, Petrucci E, Mariani G, Biffoni M, Ferretti G, Scambia G, Benedetti-Panici P, Cognetti F, Humphreys R, Peschle C, Testa U.

Apoptosis. 2007 Apr;12(4):635-55.

PMID:
17252198
17.

Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.

Zhang T, Wang X, He D, Jin X, Guo P.

Anticancer Drugs. 2014 Sep;25(8):887-97. doi: 10.1097/CAD.0000000000000116.

PMID:
24714080
18.

TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation.

Kim YH, Lee YJ.

J Cell Biochem. 2007 Mar 1;100(4):998-1009.

PMID:
17031854
19.

Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.

Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.

Prostate. 2006 Jun 15;66(9):987-95.

PMID:
16541419
20.

Supplemental Content

Support Center